Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of Circulating Tumour DNA (ctDNA) Analysis Using Automated Capillary Blood Sampling

NCT07310537 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT07310537
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07310537 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of Circulating Tumour DNA (ctDNA) Analysis Using Automated Capillary Blood Sampling
Lead sponsor
Erasmus Medical Center
Phase
Observational
Overall status
Recruiting
Start date
November 17, 2025
Completion date
November 30, 2027
Enrollment
35 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

circulating tumor dna (ctdna), colorectal cancer (diagnosis), colorectal liver metastasis (crlm)